BioCentury
ARTICLE | Company News

PRA International, WuXi PharmaTech deal

December 24, 2012 8:00 AM UTC

CROs WuXi and PRA said they will form a 51/49 JV to provide clinical research services to the Chinese market. The JV, which will be an independent CRO, will provide services including clinical trial m...